Analysis of hot spots and trends of thyroid disease omics research based on CiteSpace
QIAO Xue1 MU Silin1 CHEN Hanhan2 CHEN Hongzhi3 LI Jingwei2
1.The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250014, China; 2.Department of Breast and Thyroid Surgery, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250014, China; 3.College of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250355, China
Abstract：Objective To analyze the hotspots and trends of thyroid disease omics research based on CiteSpace. Methods The “thyroid” and “omics” were used as keywords, the relevant literatures on thyroid disease omics included in CNKI from January 2006 to July 2023 were retrieved. CiteSpace 5.7.R5 software was used to analyze the authors, institutional cooperation, and keyword co-occurrence, clustering, emergence of the included literatures, and corresponding visual knowledge maps were drawn. Results A total of 96 literatures were included, of which six were published by Liu Shumin, the author with the most papers. Heilongjiang University of Chinese Medicine and Union Hospital Affiliated to Fujian Medical University were the institutions with the largest number of publications, with four each. There were eight keyword co-occurrence clusters and 14 keywords emergent. The research focuses mainly on thyroid cancer, Graves disease, thyroid nodules, imaging, proteomics, metabolomics, and Chinese medicine. Conclusion Thyroid cancer, Hashimoto thyroiditis, and imaging may be the research trends in the future.
乔雪1 牟思霖1 陈翰翰2 陈宏志3 李静蔚2. 基于CiteSpace分析甲状腺疾病组学研究的热点与趋势[J]. 中国医药导报, 2023, 20(36): 75-78.
QIAO Xue1 MU Silin1 CHEN Hanhan2 CHEN Hongzhi3 LI Jingwei2. Analysis of hot spots and trends of thyroid disease omics research based on CiteSpace. 中国医药导报, 2023, 20(36): 75-78.
[1] 王健辉，孙蕾，冯晓伟，等.辽宁省成人甲状腺疾病流行状况及影响因素[J].中国公共卫生，2022，38（9）：1187-1192. [2] 中华医学会内分泌学分会，《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南——甲状腺疾病的实验室及辅助检查[J].中华内科杂志，2007，46（8）：697-702. [3] 陈永连，吕庆国，吴宇超，等.成都市成人碘营养及甲状腺疾病患病情况的调查研究[J].四川大学学报（医学版），2022，53（4）：649-655. [4] Jung KW，Won YJ，Kong HJ，et al. Cancer statistics in Korea：incidence，mortality，survival，and prevalence in 2012 [J]. Cancer Res Treat，2015，47（2）：127-141. [5] Li Y，Teng D，Ba J，et al. Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders：Epidemiological Evidence from 31 Provinces of Mainland China [J]. Thyroid，2020，30（4）：568-579. [6] Enewold L，Harlan LC，Stevens JL，et al. Thyroid cancer presentation and treatment in the United States [J]. Ann Surg Oncol，2015，22（6）：1789-1797. [7] Huo P，Zhu Y，Liang C，et al. Non-invasive Amino Acid Profiling of Embryo Culture Medium Using HPLC Correlates With Embryo Implantation Potential in Women Undergoing in vitro Fertilization [J]. Front Physiol，2020，11：1-10. [8] 李增华，夏春华，胡大涛，等.基于T2WI及动态对比增强MRI的影像组学模型预测肾细胞癌亚型[J].中国临床研究，2023，36（1）：34-39. [9] 寿鑫甜，王禹萌，段城林，等.心血管疾病组学研究相关文献的可视化分析[J].中国循证心血管医学杂志，2023， 15（2）：135-139，149. [10] 曾奕斐，陈宏志，李静蔚.自身免疫性甲状腺疾病的代谢组学研究进展[J].中国临床研究，2021，34（12）：1714- 1716. [11] 赵彤，胡星月，杨伟振.影像组学在结直肠癌中应用的研究进展[J].中国医药科学，2023，13（5）：78-81. [12] Gulfidan G，Soylu M，Demirel D，et al. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks [J]. Arch Biochem Biophys，2022， 715：1-12. [13] Luvhengo TE，Bombil I，Mokhtari A，et al. Multi-Omics and Management of Follicular Carcinoma of the Thyroid [J]. Biomedicines，2023，11（4）：1-28. [14] 李妙媛，韦星成，唐坤泉，等.代谢组学在儿科领域的研究进展[J].中国医药科学，2023，13（13）：47-50. [15] 姚雪，徐川平，李杰，等.基于普赖斯定律和二八定律及在线投稿系统构建某科技期刊核心作者用户库[J].编辑学报，2017，29（1）：64-66. [16] 赵小晗，高洁，谭宇，等.基于文献计量学对中医药干预氧化应激的可视化分析[J].天津中医药，2023，40（6）：715-725. [17] 陈悦，陈超美，刘则渊，等.CiteSpace知识图谱的方法论功能[J].科学学研究，2015，33（2）：242-253. [18] 赵金椽，南洋，陈平平，等.知母多糖对甲亢热证大鼠肝脏代谢的影响[J].中医药信息，2022，39（4）：31-35. [19] 张宁，李自辉，赵洪伟，等.基于转录组测序技术研究玄参提取物干预阴虚火旺甲状腺功能亢进大鼠的分子机制[J].中华中医药杂志，2022，37（2）：709-713. [20] 张宁，李自辉，赵洪伟，等.基于iTRAQ技术的玄参对阴虚火旺甲状腺功能亢进大鼠蛋白质组学研究[J].中华中医药杂志，2021，36（7）：4207-4211. [21] 张宁，李自辉，赵洪伟，等.玄参对甲亢模型大鼠血清内源性标志物的影响[J].时珍国医国药，2019，30（5）：1079- 1083. [22] 张宁，李自辉，赵洪伟，等.玄参提取物对甲亢模型大鼠肝脏代谢组学的影响[J].北京中医药大学学报，2019， 42（1）：21-29. [23] 张宁，李自辉，赵洪伟，等.基于尿液代谢组学研究玄参对阴虚火旺甲亢大鼠的滋阴降火作用机制[J].药学学报，2018，53（11）：1843-1851. [24] 牧亚峰，向楠，曾明星，等.基于系统生物学组学技术的甲状腺疾病中医药研究与应用[J].中国医药导报，2020，17（15）：41-44. [25] Gillies RJ，Kinahan PE，Hricak H. Radiomics：Images Are More than Pictures，They Are Data [J]. Radiology，2016，278 （2）：563-577. [26] 高伟，唐伟.甲状腺肿瘤代谢组学的研究进展[J].癌症进展，2020，18（2）：113-116. [27] Sofiadis A，Becker S，Hellman U，et al. Proteomic profiling of follicular and papillary thyroid tumors [J]. Eur J Endocr- inol，2012，166（4）：657-667. [28] Smith A，Galli M，Piga I，et al. Molecular signatures of med- ullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging [J]. J Proteomics，2019，191：114-123. [29] Dai YK，Zhao ZM，Liu C. Treatment of Liver Fibrosis：A 20- Year Bibliometric and Knowledge-Map Analysis [J]. Front Pharmacol，2022，13：1-18.
2023, Vol. 20 
京公网安备 11010502046598号